Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

NCT00700258 · clinicaltrials.gov ↗

COMPLETED

Status

1520

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell, Advanced
Lymphoma, Mantle-Cell
Gastrointestinal Stroma Tumors

Interventions

DRUG: Temsirolimus
DRUG: Temsirolimus
DRUG: Sunitinib
DRUG: Sunitinib
DRUG: Axitinib

Sponsor

Pfizer